CIK 0001736243
- Emerging growth company
Acurx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ACXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 917-533-1469
- Business address
- 259 LIBERTY AVENUE, STATEN ISLAND, NY, 10305
- Former names
- Acurx Pharmaceuticals, LLC
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
Page 1 of 1 · 13 filings